Evidence map›Paper›PMID 42318098›Full record

ArticleFrontiers in psychiatry2026

Reduced serum cortisol, IGF-1, GLP-1, and T3 levels in medication-free children and adolescents with obsessive-compulsive disorder: a case-control study.

Fatma Coşkun, Hasibe Ağır, Rukiye Esra Ildız, İbrahim Kılınç, Necati Uzun, Emine Göktaş, Ahmet Osman Kılıç

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Fatma CoşkunDepartment of Child and Adolescent Psychiatry, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
Hasibe AğırDepartment of Child and Adolescent Psychiatry, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
Rukiye Esra IldızDepartment of Child and Adolescent Psychiatry, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
İbrahim KılınçDepartment of Biochemistry, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
Necati UzunDepartment of Child and Adolescent Psychiatry, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
Emine GöktaşDepartment of Medical Genetics, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.
Ahmet Osman KılıçDepartment of Pediatrics, Faculty of Medicine, Necmettin Erbakan University, Konya, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Obsessive-compulsive disorder (OCD) frequently emerges during childhood and adolescence and has been associated with alterations in multiple neurobiological systems. Neuroendocrine pathways involved in stress regulation, neurodevelopment, metabolic signaling, and thyroid function interact closely to influence brain circuits implicated in OCD. However, studies simultaneously examining several neuroendocrine parameters in pediatric OCD remain limited. Methods: This case-control study included 52 medication-free children and adolescents with OCD and 42 healthy controls aged 8-17 years. Psychiatric diagnoses were established using the Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL) according to DSM-5 criteria. Obsessive-compulsive symptom severity was assessed using the Children's Yale-Brown Obsessive Compulsive Scale (CY-BOCS). Anxiety and depressive symptoms were evaluated using the Screen for Child Anxiety Related Emotional Disorders (SCARED) and the Children's Depression Inventory (CDI), respectively. Serum levels of adrenocorticotropic hormone (ACTH), cortisol, growth hormone (GH), Insulin-like growth factor-1 (IGF-1), Glucagon-like peptide-1 (GLP-1), relaxin-3 (RLN-3), triiodothyronine (T3), and thyroid-stimulating hormone (TSH) were measured using ELISA. Group differences were examined using covariance-based models controlling for age, sex, BMI percentile, anxiety (SCARED), and depressive symptoms (CDI). Results: Initial analyses showed that children and adolescents with OCD had significantly lower serum levels of cortisol, IGF-1, GLP-1, and T3 compared with healthy controls. These differences remained significant after controlling for age, sex, BMI percentile, and the SCARED and CDI total score, with adjusted analyses showing lower levels of cortisol (p = 0.003), IGF-1 (p = 0.013), GLP-1 (p = 0.017), and T3 (p = 0.015) in the OCD group. Correlation analyses did not reveal significant associations between biochemical parameters and OCD symptom severity after correction for multiple comparisons. Discussion: These findings suggest that pediatric OCD may be associated with alterations in several neuroendocrine pathways rather than isolated changes within a single hormonal system. Further longitudinal studies are needed to better clarify the biological basis and clinical significance of these findings.

Indexed as

adrenocorticotropic hormonecortisolglucagon-like peptide-1growth hormoneinsulin-like growth factor-1obsessive–compulsive disorderrelaxin-3triiodothyronine

Identifiers

PMID42318098
PMCPMC13272417

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.